What Langland does

Langland is a London-headquartered healthcare communications agency operating as a subsidiary of Publicis Health within the broader Publicis Groupe. Founded in 1991, the agency employs 240+ professionals across offices in London, New York, and Sydney, serving pharmaceutical, biotech, and life sciences clients. Since 2020, the four previously distinct disciplines — Clinical Trial Experience, Medical Strategy & Education, Public Relations & Engagement, and Advertising — have been operated under a single unified agency brand using a "THINK FURTHER" methodology that emphasizes cross-disciplinary integration and diverse team perspectives. Client work spans clinical trial patient recruitment and site staff communications, medical affairs and education, patient advocacy campaigns, disease awareness programs, and brand advertising for regulated healthcare products.

The business model is professional services-based: revenue is generated through custom enterprise engagements with pharma and biotech clients, with no publicly disclosed pricing or productized offerings. Go-to-market relies on direct enterprise sales relationships, supplemented by thought leadership content, industry conference presence (Cannes Lions, SCOPE, HLTH Europe, Medical Affairs Professional Society), and earned media coverage in healthcare trade publications. Langland has invested heavily in leadership, executing a coordinated Q1 2024 management overhaul that promoted two Group Managing Directors and added a Managing Partner for Advertising hired from competitor Avalere Health. The agency holds a board seat at the Healthcare Communications Association and co-published an industry AI roadmap.

Langland's technology and data footprint is conventional for a creative agency. There are no proprietary technology platforms, patents, AI/ML products, or disclosed data assets. The agency uses standard marketing automation and analytics (Google Analytics, advertising pixels), participates in Publicis Groupe-wide data practices, and contributes to industry-level AI discourse through the HCA, but does not operate an AI-native product or maintain a data flywheel that would constitute a technology moat.

Name

Langland

Legal name

Langland

Website

https://publicislangland.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

251–500 employees

Short description

Langland is a healthcare communications agency and subsidiary of Publicis Health, employing 240+ experts across London, New York, and Sydney. It serves pharmaceutical, biotech, and life sciences clients with clinical trial communications, medical strategy, public relations, and advertising services.

Ownership category

akta.pro rank

Product category

Healthcare Communications Services

NAICS

Advertising Agencies (541810), Advertising, Public Relations, and Related Services (5418)

SIC

Services-Advertising Agencies (7311), Services-Health Services (8000)

akta.pro primary industry

Healthcare/Pharma Creative Agencies (MPAAAAAJ)

akta.pro secondary industry

Healthcare & Life Sciences PR (MPAAADAD)

Keywords

• Healthcare communications services
• Clinical trial communications
• Medical strategy education
• Pharmaceutical advertising agency
• Healthcare public relations

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Healthcare Communications Services: Full-service healthcare advertising agency providing clinical trial experience, medical strategy and education, public relations, and advertising services to pharmaceutical and healthcare clients.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Langland is a full-service healthcare communications agency delivering four interconnected disciplines: Clinical Trial Experience (creative branding and communications for clinical trial patients, site staff and HCPs), Medical Strategy & Education (strategic narratives, workshops, and medical education programs for pharmaceutical and biotech clients), Public Relations & Engagement (corporate and brand communications, patient programmes, social media and influencer campaigns), and Advertising (global brand campaigns, materials, experiences and activations). Services are delivered through custom consultancy engagements to pharmaceutical, biotech, life sciences, and healthcare-charity clients across offices in London, New York, and Sydney.

Product overview

Langland is a healthcare communications agency operating as part of Publicis Health, offering four interconnected service disciplines: Clinical Trial Experience (branding and communications for clinical trials), Medical Strategy & Education (strategic narratives, workshops, and medical education), Public Relations & Engagement (corporate communications, patient programmes, social media campaigns), and Advertising (brand campaigns and activations). The agency follows a 'THINK FURTHER' methodology that emphasizes diverse perspectives and cross-disciplinary collaboration to create industry-defining work. Services are delivered through a consultancy engagement model rather than a software-as-a-product platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Experience Creative agency services for clinical trials, combining art and science to create branding and communications that elevate patient, site staff and HCP understanding and motivate engagement across the trial lifecycle.
• Medical Strategy & Education Strategic narratives, workshops, and medical education services that advance clinical care through insight-driven communications centred on audience needs for pharmaceutical, biotech and life sciences clients.
• Public Relations & Engagement Corporate and brand communications, patient programmes, social media and influencer campaigns spanning data and brand communications, leadership communications, advocacy, internal communications, and social media activation.
• Advertising Global brand campaigns, materials, experiences and activations that cut through content saturation with simple, surprising, and empathetic creativity to guide patients and professionals in health decisions.

Quantifiable outcome

• Mind campaign achieved 4.2M engagements, 28.3M impressions, 40% increase in enquiries
• +1 more outcomes

Named customers4 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core, parent and minor.

• White City Innovation DistrictcoreStrategic or Co-development Partner · 11 February 2025Langland is based in the BBC Television Centre near the White City Innovation District. Ecosystem partners include Imperial College London, Novartis, Autolus, GammaDelta, and Synthace. Langland sponsored the Jawdrop Summit 2025.
• Healthcare Communications Association (HCA)coreStrategic or Co-development Partner · 6 October 2023Langland contributed to the HCA AI Roadmap position paper published in Current Medical Research and Opinion. HCA is the leading professional association for healthcare communications.
• Publicis HealthparentStrategic or Co-development PartnerLangland is a Publicis Health company, part of the Publicis Groupe global communications holding company. This provides access to the broader Publicis network resources and the 'Power of One' integrated offering.
• Imperial College LondoncoreStrategic or Co-development PartnerAcademic partner in White City Innovation District, collaborating on healthcare innovation and research initiatives
• Max's FoundationminorStrategic or Co-development PartnerCharity co-founded by Langland Senior Medical Writer Molly Schiller, supporting research and awareness for inherited heart conditions including hypertrophic cardiomyopathy (HCM)
• Great Ormond Street Hospital (GOSH)minorStrategic or Co-development PartnerMax's Foundation partnered with GOSH's Centre for Inherited Cardiovascular Diseases to fund research positions and support the GOSH BIOPIC Study
• Upstream Nexus (Hammersmith & Fulham Council and Imperial College London)minorStrategic or Co-development PartnerPartnership organizing the Jawdrop Summit - an annual event bringing together industry, academia, and investors in the White City Innovation District
• Healthcare Communications Association BoardminorGTM or Marketing PartnerAnnabelle Sandeman (Publicis Health Chief Growth Officer) holds a board position at HCA, uniting agencies and pharmaceutical companies in advocating for the sector

Scale indicators2 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Digitas Health: Publicis Health sibling agency operating in the digital health and customer experience space, sharing leadership and growth infrastructure with Langland. Competes for the same pharma/biotech digital engagement and CRM mandates and frequently pitches jointly or against Langland.
• Havas Health & You: Havas-owned global healthcare communications network providing creative, medical, PR, and digital services to pharma and consumer health clients. Comparable in scale, structure, and target market to Langland's Publicis Health operation.
• FCB Health: IPG-owned healthcare creative and medical communications agency offering advertising, medical education, and patient engagement services. Operates in the same enterprise pharma/biotech pitch environment as Langland.
• Real Chemistry: Independent healthcare communications and marketing agency offering advertising, PR, and data-driven patient engagement comparable to Langland. Competes for the same mid-to-large pharma and biotech accounts.
• GCI Health: Specialist healthcare PR and communications agency owned by WPP, with comparable PR & Engagement, advocacy, and disease awareness offerings to Langland. Direct competitor for the same pharma and nonprofit health clients.
• McCann Health: IPG-owned global healthcare communications network with a comparable four-discipline offering (advertising, medical education, PR, clinical trial communications). Operates in similar geographies and serves overlapping pharma/biotech enterprise clients.
• Syneos Health Communications: Communications arm of Syneos Health (now Cognizant), offering advertising, PR, and medical communications with deep clinical trial integration. Comparable to Langland's Clinical Trial Experience discipline and competes for the same enterprise pharma clients.
• Ogilvy Health: WPP-owned global healthcare communications network offering advertising, medical education, PR, and patient engagement services to pharma and biotech. Directly comparable to Langland in scope (clinical trial experience, med affairs, creative advertising) and in target clients across Europe and North America.
• Saatchi & Saatchi Wellness: Direct sister agency under Publicis Health UK alongside Langland, sharing the same CEO and growth officer. Offers healthcare advertising, PR, and medical strategy services to pharmaceutical and consumer health clients globally, making it the closest internal comparator for Langland's offering.
• Spectrum Science: Independent global health and science communications agency offering advertising, medical strategy, and integrated communications comparable to Langland's offering. Operates across North America and Europe with similar pharma/biotech client focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Langland